Volume 21, Number 9—September 2015
Letter
Functional Immune Reconstitution by Interleukin-2 Adjunctive Therapy for HIV/Mycobacterial Co-infection
Figure

Figure. Laboratory findings and drug treatment regimen over time for an HIV-infected patient with disseminated Mycobacterium tilburgii infection, December 2006–October 2014. A) CD4+ T cell count, HIV viral load, and use of interleukin-2 (IL-2; gray shading). B) antimycobacterial drug combinations, antiretroviral therapy (ART), and trimethoprim/sulfamethoxazole prophylaxis.